This article is more than 5 years old. Information may no longer be current.

STAAR reports $18.8 million in net sales in third quarter

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

STAAR Surgical reported $18.8 million in net sales in the third quarter compared to $18.2 million reported in the same quarter in 2014, the company announced in a press release.

The overall 3% sales increase was attributed to higher ICL unit sales in each region – 37% in Europe, Middle East and Africa, 13% in Asia Pacific and 10% in North America – offset by a 24% decrease in worldwide IOL revenue and foreign currency changes, according to the release.

Operating expenses were reported at $14.8 million, a 10% increase compared to $13.4 million reported in the same quarter of 2014. The increase was due to a bonus accrual reversal of $1.6 million in the prior year period.

Adjusted net loss was reported at $40,000, or breakeven on a per share basis, compared to $87,000, or breakeven per diluted share, for the same period in 2014.